ClinicalTrials.Veeva

Menu

Decrease of Post-operative Complications by SCVO2 Monitoring an Optimisation of Cardiac Flow (OCOSO2)

P

Public Assistance-Hospitals of Marseille (AP-HM)

Status

Completed

Conditions

Cardiac Flow

Treatments

Procedure: ScvO2 Perioperative continue monitoring

Study type

Interventional

Funder types

Other

Identifiers

NCT03828565
2018-37
IDRCB (Other Identifier)

Details and patient eligibility

About

In operating theater, one of the bigger purpose of anesthetist-resuscitator is to optimize vascular filling (VF) because of a failure or an excess of filling is deleterious for the patient. Several studies have assessed the traditionnal VF based on the clinic and the VF guided by quantitative critereas. Thus studies have showed a decrease of morbidity and duration of patients' stay whose the VF was guided even on the long term. So, formal recommandations of experts (FRE) on the perioperative filling strategy of the SFAR ( Anesthesia and Resuscitation Francophone Society) advise to titrate the perioperative vascular filling of high risk patients guiding on a mesure of end-systolic volume (ESV). The inscrease of ESV answering to filling confirmed the VF realized is relevant and authorized its pursuite while the absence of an increase of the ESV after a filling test signifies the useless and deleterious character of this one. The optimization of perioperative hemodynamics consists in adapting the patient's cardiac output to his metabolic needs. ETO, Swan-Ganz: limit of its application to the routine. The central venous oxygen saturation (ScvO2) is simple and safe, the evaluation of the adjustment of O2 inputs compared to the needs. The industry has developed continuous monitoring systems by reflection spectrophotometry using optical fibers installed in the central venous pathways. In daily practice, the stricto sensu application of FRE leads to administering an VF up to the limit of the preload dependence without evaluating the adequacy of the cardiac output, which is not a physiological situation. This filling is therefore sometimes performed solely on the criteria of preload dependence while it is potentially deleterious for the patient. No study has compared a strategy based on the use of ScvO2 and preload dependence with current recommendations based solely on preload dependence. Our hypothesis is that the continuous monitoring of the ScvO2 in the superior cave territory in intraoperative would allow to detect the patients with an inadequacy of the cardiac output and thus to select the only ones requiring a vascular filling. This would reduce postoperative complications related to overfilling, without exposing the patient to episodes of tissue hypoperfusion.

Enrollment

220 patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • >50 years old
  • ASA score ≥ 2
  • requiring a major intra-abdominal scheduled surgery
  • lasting more than 90 min
  • in the visceral surgery, vascular surgery, urological surgery and gynecological surgery sectors

Exclusion criteria

  • <18 years old
  • Pregnant or brest feeding patients
  • no consentement
  • Unstable acute pathology at the time of surgery (acute heart, respiratory or renal failure, severe sepsis or septic shock, hemorrhagic shock);
  • rhythm disorders type ACFA early intervention;
  • Palliative surgery, ASA 5;
  • Patient under guardianship or curatorship.

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

220 participants in 2 patient groups

ScvO2 group
Active Comparator group
Description:
ScvO2 and Pulse Pressure Variation (PPV) : every 30 min (%) ScvO2 Evolution in case of corrective maneuver (%) PPV evolution in case of filling test (%)
Treatment:
Procedure: ScvO2 Perioperative continue monitoring
Control group
No Intervention group
Description:
End-systolic Volume (ESV) : every 30 min (mL) ESV evolution in case of filling test (%)

Trial contacts and locations

1

Loading...

Central trial contact

Laurent ZIELESKIEWICZ, Dr

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems